{"id":"allogeneic-mesenchymal-stem-cells","safety":{"commonSideEffects":[{"rate":"null","effect":"Infusion-related reactions"},{"rate":"null","effect":"Infection"},{"rate":"null","effect":"Tumor lysis syndrome"}]},"_chembl":{"chemblId":"CHEMBL5315108","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This mechanism is believed to promote tissue repair and modulate the immune response, potentially leading to therapeutic benefits in various conditions. The exact mechanisms of action are not fully understood and may involve multiple pathways. Further research is needed to fully elucidate the effects of Allogeneic Mesenchymal Stem Cells on the body.","oneSentence":"Allogeneic Mesenchymal Stem Cells are thought to exert immunomodulatory effects through the release of anti-inflammatory cytokines and growth factors.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T03:21:21.793Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of graft-versus-host disease"}]},"trialDetails":[{"nctId":"NCT07498218","phase":"PHASE1","title":"Phase 1 Study of VELGRAFT, a Living Cellular Construct, in the Management of Chronic Diabetic Foot Ulcers Which Have Attained Granulation Tissue","status":"NOT_YET_RECRUITING","sponsor":"Ayu, Inc.","startDate":"2026-03-02","conditions":"Diabetic Foot Ulcer (DFU), Granulation of Chronic Diabetic Wounds","enrollment":24},{"nctId":"NCT06905834","phase":"PHASE2","title":"Evaluation of Allogenic Mesenchymal Stem Cell (MSC) Injection Therapy for Refractory Graft-versus-Host Disease (GVHD) Unresponsive to Conventional Treatments","status":"NOT_YET_RECRUITING","sponsor":"Instituto de Investigación Biomédica de Salamanca","startDate":"2026-05","conditions":"Dry Eye Disease (DED), Graft-Versus-Host Disease(GVHD)","enrollment":30},{"nctId":"NCT04476901","phase":"PHASE2","title":"Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy","status":"RECRUITING","sponsor":"Joshua M Hare","startDate":"2021-05-07","conditions":"Non-ischemic Dilated Cardiomyopathy","enrollment":136},{"nctId":"NCT02032004","phase":"PHASE3","title":"Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2014-03-03","conditions":"Chronic Heart Failure","enrollment":565},{"nctId":"NCT07048314","phase":"PHASE1, PHASE2","title":"Stem Cells for Erectile Dysfunction Post RALP","status":"NOT_YET_RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2026-03-10","conditions":"Erectile Dysfunction, Prostate Cancer","enrollment":40},{"nctId":"NCT07238062","phase":"","title":"\"An Intermediate Size Patient Population Expanded Access Protocol to Evaluate the Safety and Efficacy of Allogeneic HB-adMSCs (Hope Biosciences - Adipose Derived Mesenchymal Stem Cells) for the Treatment of Multiple System Atrophy.\"","status":"TEMPORARILY_NOT_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Multiple System Atrophy","enrollment":""},{"nctId":"NCT03896568","phase":"PHASE1","title":"MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2019-02-12","conditions":"IDH1 wt Allele, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma","enrollment":36},{"nctId":"NCT07449364","phase":"NA","title":"Allogeneic Human Mesenchymal Stem Cell Infusion for Frailty Patient","status":"COMPLETED","sponsor":"Daewoong Group Indonesia","startDate":"2025-03-24","conditions":"Frailty in Older Adults","enrollment":10},{"nctId":"NCT06654193","phase":"PHASE1, PHASE2","title":"Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury","status":"RECRUITING","sponsor":"Hope Biosciences LLC","startDate":"2026-02-01","conditions":"Acute Kidney Injury","enrollment":70},{"nctId":"NCT07431645","phase":"PHASE1","title":"Pilot Study of Radiation-Induced Xerostomia Treatment With Allogeneic Mesenchymal Stromal Stem Cells","status":"COMPLETED","sponsor":"Institute of Oncology Ljubljana","startDate":"2023-04-01","conditions":"Radiation-Induced Xerostomia, Head and Neck Cancer","enrollment":10},{"nctId":"NCT07441720","phase":"PHASE2","title":"Safety and Efficacy of Umbilical Cord Blood Therapy for Cancer Therapy-Induced Thrombocytopenia (CTIT)","status":"RECRUITING","sponsor":"Zhejiang Cancer Hospital","startDate":"2026-02-28","conditions":"Thrombocytopenia, Cancer Treatment-induced Thrombocytopenia","enrollment":25},{"nctId":"NCT04314687","phase":"PHASE1, PHASE2","title":"Stem Cell and Conditioned Medium for Cerebral Palsy","status":"ACTIVE_NOT_RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2021-10-13","conditions":"Cerebral Palsy","enrollment":78},{"nctId":"NCT04314661","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem Cell Therapy (MSCs) and Conditioned Medium Therapy for Osteoartrithis","status":"COMPLETED","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2020-08-03","conditions":"Osteoarthritis, Knee","enrollment":31},{"nctId":"NCT04357600","phase":"PHASE1, PHASE2","title":"Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B","status":"ENROLLING_BY_INVITATION","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2018-05-17","conditions":"Liver Cirrhoses","enrollment":12},{"nctId":"NCT05786287","phase":"","title":"Long-term Safety of UC-MSC Transplantation in Patients With Retinitis Pigmentosa","status":"NOT_YET_RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2026-05","conditions":"Retinitis Pigmentosa","enrollment":18},{"nctId":"NCT05909488","phase":"PHASE2, PHASE3","title":"Role of UC-MSC and CM to Inhibit Vision Loss in Retinitis Pigmentosa Phase I/II","status":"NOT_YET_RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2026-05","conditions":"Retinitis Pigmentosa","enrollment":30},{"nctId":"NCT03158896","phase":"PHASE1","title":"Evaluation of Umbilical Cord-Derived Wharton's Jelly Stem Cells for the Treatment of Acute Graft Versus Host Disease","status":"COMPLETED","sponsor":"University of Kansas Medical Center","startDate":"2018-07-09","conditions":"Acute Graft Versus Host Disease","enrollment":24},{"nctId":"NCT06918808","phase":"PHASE2","title":"DB-3Q bmMSC-EVs in Patients With Perianal Fistulizing Crohn's Disease","status":"RECRUITING","sponsor":"Direct Biologics, LLC","startDate":"2025-05-19","conditions":"Perianal Fistula Due to Crohn's Disease","enrollment":36},{"nctId":"NCT07077746","phase":"PHASE2","title":"HB-adMSCs for the Treatment of Crohn's Disease","status":"RECRUITING","sponsor":"Hope Biosciences Research Foundation","startDate":"2026-03","conditions":"Crohn Disease (CD)","enrollment":46},{"nctId":"NCT07400328","phase":"PHASE2","title":"Amimestrocel Injection for Preventing Severe Oral Mucositis in HSCT Patients","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2026-01-15","conditions":"Oral Mucositis, Stomatitis, Gastrointestinal Mucositis","enrollment":22},{"nctId":"NCT07396155","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy in Diabetic Nephropathy Patients: A Clinical Trial","status":"RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2026-07-01","conditions":"Diabetic Nephropathy Type 2","enrollment":10},{"nctId":"NCT07304440","phase":"PHASE1, PHASE2","title":"Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study","status":"RECRUITING","sponsor":"Adia Med of Winter Park LLC","startDate":"2026-01-12","conditions":"Autism Spectrum Disorder, Autism, ASD","enrollment":100},{"nctId":"NCT06840275","phase":"PHASE2","title":"ASCs in Recently Diagnosed Non-ischemic Heart Failure","status":"NOT_YET_RECRUITING","sponsor":"Cell to Cure ApS","startDate":"2026-03-01","conditions":"Non-Ischemic Heart Failure, Reduced Ejection Fraction Heart Failure","enrollment":90},{"nctId":"NCT02633163","phase":"PHASE2","title":"Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE)","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2018-11-18","conditions":"Systemic Lupus Erythematosus","enrollment":81},{"nctId":"NCT05553132","phase":"PHASE1","title":"A Study of REcycled CartiLage Auto/Allo IMplantation to Treat and Repair Focal Hip Cartilage Defects","status":"ACTIVE_NOT_RECRUITING","sponsor":"Daniel B. F. Saris","startDate":"2023-08-08","conditions":"Cartilage Defect","enrollment":15},{"nctId":"NCT01733186","phase":"PHASE1, PHASE2","title":"Evaluation of Safety and Exploratory Efficacy of CARTISTEM®, a Cell Therapy Product for Articular Cartilage Defects","status":"COMPLETED","sponsor":"Medipost, Inc.","startDate":"2013-01-07","conditions":"Degeneration Articular Cartilage Knee","enrollment":12},{"nctId":"NCT06919081","phase":"PHASE2","title":"Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease","status":"RECRUITING","sponsor":"University of Illinois at Chicago","startDate":"2025-08-01","conditions":"Persistent Corneal Epithelial Defect, Corneal Epithelial Disorders","enrollment":24},{"nctId":"NCT07374679","phase":"","title":"Long-Term Follow-up Study to Evaluate Long-Term Safety and Efficacy of Allogenic Umbilical Cord-derived Mesenchymal Stem Cell in Patients With Rotator Cuff Disease","status":"NOT_YET_RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2026-01-26","conditions":"Rotator Cuff Disease","enrollment":21},{"nctId":"NCT06752577","phase":"","title":"Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2024-12-22","conditions":"Chronic Kidney Diseases, Kidney Transplant","enrollment":75},{"nctId":"NCT06075706","phase":"PHASE2","title":"Trial of Efficacy and Safety of MC0518 Versus Best Available Therapy in Participants With Steroid-Refractory Acute Graft Versus Host Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"medac GmbH","startDate":"2023-11-13","conditions":"Steroid-refractory Acute Graft-versus-host Disease","enrollment":48},{"nctId":"NCT02677350","phase":"PHASE1","title":"AlloGeneic Human Mesenchymal Stem Cells (hMSC) in PAtients With FistuLizing Crohn's Disease Via PErifistula iNjEctions (GALENE)","status":"WITHDRAWN","sponsor":"Joshua M Hare","startDate":"2019-12-01","conditions":"Crohn's Disease, Fistulizing Crohn's Disease, Stem Cells","enrollment":""},{"nctId":"NCT07367815","phase":"PHASE1, PHASE2","title":"Allogeneic Adipose Tissue Derived-stem Cells in Alzheimer Disease","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2026-03-01","conditions":"Alzheimer Disease","enrollment":9},{"nctId":"NCT07143812","phase":"PHASE1","title":"A Study to Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients With Newly Diagnosed Glioblastoma","status":"RECRUITING","sponsor":"CHA University","startDate":"2025-10-23","conditions":"Glioblastoma (GBM), Newly Diagnosed Glioblastoma Multiforme","enrollment":10},{"nctId":"NCT06001853","phase":"PHASE2","title":"Allogeneic BM-MSC's in Patients With Lumbar Facet Arthropathy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2023-11-03","conditions":"Facet-Mediated Low Back Pain","enrollment":40},{"nctId":"NCT03265808","phase":"PHASE1, PHASE2","title":"Allogeneic Human Mesenchymal Stem Cell Infusion vs Placebo in Alcohol Use Disorder and Major Depression.","status":"COMPLETED","sponsor":"Ihsan M Salloum, MD, MPH","startDate":"2018-03-18","conditions":"Major Depressive Disorder, Alcohol Use Disorder","enrollment":31},{"nctId":"NCT07329569","phase":"PHASE2","title":"Treatment of Severe Ocular Chemical Burns by Subconjunctival Injection of Allogeneic Mesenchymal Stem Cells: An Open-Label, Single-Arm, Multicenter Phase II Trial","status":"NOT_YET_RECRUITING","sponsor":"Fondation Ophtalmologique Adolphe de Rothschild","startDate":"2026-03","conditions":"Chemical Burns, Ocular Burns","enrollment":21},{"nctId":"NCT06623240","phase":"PHASE2","title":"HB-adMSCs vs Placebo for the Treatment of Juvenile Idiopathic Arthritis","status":"WITHDRAWN","sponsor":"Hope Biosciences Research Foundation","startDate":"2026-01","conditions":"Juvenile Idiopathic Arthritis (JIA)","enrollment":""},{"nctId":"NCT05491681","phase":"PHASE1","title":"AllogeneiC Expanded Human MSC Therapy in Patients Recovering From COVID-19 Acute Respiratory Distress Trial","status":"WITHDRAWN","sponsor":"BioCardia, Inc.","startDate":"2026-01-04","conditions":"ARDS, Human","enrollment":""},{"nctId":"NCT02962661","phase":"PHASE1","title":"Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2020-07-18","conditions":"Cardiomyopathy, Heart Failure, Hematopoietic and Lymphoid Cell Neoplasm","enrollment":72},{"nctId":"NCT04434768","phase":"PHASE1","title":"Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Ischemic Stroke","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ever Supreme Bio Technology Co., Ltd.","startDate":"2020-12-02","conditions":"Acute Stroke","enrollment":10},{"nctId":"NCT07240987","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem Cells for Chronic Kidney Diseases","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of Air Force Medicial University","startDate":"2026-01-01","conditions":"Kidney Disease, Chronic, Diabetic Kidney Disease (DKD), Hypertensive Nephropathy","enrollment":32},{"nctId":"NCT04995081","phase":"PHASE2","title":"Clinical Trial for Parkinson's Disease Using Allogeneic HB-adMSCs (Early and Moderate PD)","status":"COMPLETED","sponsor":"Hope Biosciences Research Foundation","startDate":"2021-07-16","conditions":"Parkinson Disease","enrollment":60},{"nctId":"NCT06328712","phase":"PHASE1","title":"Evaluate the Safety and Efficacy of EN001 in Patients With Charcot-Marie-Tooth Disease Type 1A","status":"COMPLETED","sponsor":"ENCell","startDate":"2024-05-30","conditions":"Charcot-Marie-Tooth Disease Type 1A","enrollment":6},{"nctId":"NCT07290946","phase":"PHASE2","title":"Repeated Mesenchymal Stem Cell Therapy for Radiation-Induced Hyposalivation and Xerostomia in Head and Neck Cancer Survivors","status":"NOT_YET_RECRUITING","sponsor":"Christian von Buchwald","startDate":"2025-12","conditions":"Xerostomia Due to Hyposecretion of Salivary Gland, Xerostomia Due to Radiotherapy, Sjögren´s Syndrome","enrollment":100},{"nctId":"NCT05705024","phase":"PHASE2","title":"Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells","status":"RECRUITING","sponsor":"University of Illinois at Chicago","startDate":"2023-09-29","conditions":"Corneal Ulcer","enrollment":38},{"nctId":"NCT05925608","phase":"PHASE1, PHASE2","title":"Clinical Trial of Human Allogenic Culture-expanded Bone Marrow-derived Mesenchymal Stem Cells","status":"ACTIVE_NOT_RECRUITING","sponsor":"BioCardia, Inc.","startDate":"2023-08-23","conditions":"Heart Failure, Systolic","enrollment":39},{"nctId":"NCT07164482","phase":"","title":"Intermediate Size Patient Population Expanded Access Protocol to Evaluate HB-adMSCs for the Treatment of Patients With Traumatic or Nontraumatic Brain Injury","status":"AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Brain Injury","enrollment":""},{"nctId":"NCT06578039","phase":"PHASE1","title":"Phase 1 Clinical Trial of CordSTEM-ST","status":"COMPLETED","sponsor":"CHABiotech CO., Ltd","startDate":"2024-08-30","conditions":"Premature Ovarian Insufficiency","enrollment":6},{"nctId":"NCT05559801","phase":"PHASE1, PHASE2","title":"Mesenchymal Cell Therapy in Osteogenesis Imperfecta (OI)","status":"NOT_YET_RECRUITING","sponsor":"Emory University","startDate":"2026-02","conditions":"Osteogenesis Imperfecta, Osteogenesis Imperfecta Type III","enrollment":12},{"nctId":"NCT05789394","phase":"PHASE1","title":"Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2023-06-16","conditions":"Recurrent Glioblastoma, IDH-Wildtype, Recurrent Astrocytoma, IDH-Mutant, Grade 4, Astrocytoma, Grade IV","enrollment":20},{"nctId":"NCT01071577","phase":"","title":"Collection of Bone Marrow From Healthy Volunteers and Patients for the Production of Clinical Bone Marrow Stromal Cell (BMSC) Products","status":"TERMINATED","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2010-03-17","conditions":"Bone Marrow Stromal Cells","enrollment":65},{"nctId":"NCT04087889","phase":"","title":"Individual Patient Expanded Access IND of Hope Biosciences First Blood Relative Allogeneic Adipose-derived Mesenchymal Stem Cells (HB-adMSCs) for Pancreatic Cancer","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences LLC","startDate":"","conditions":"Pancreatic Cancer","enrollment":""},{"nctId":"NCT04348435","phase":"PHASE2","title":"A Randomized, Double-Blind, Single Center, Efficacy and Safety Study of Allogeneic HB-adMSCs Against COVID-19.","status":"COMPLETED","sponsor":"Hope Biosciences Research Foundation","startDate":"2020-05-14","conditions":"COVID-19","enrollment":53},{"nctId":"NCT05126563","phase":"PHASE2","title":"Randomized Double-Blind Phase 2 Study of Allogeneic HB-adMSCs for the Treatment of Chronic Post-COVID-19 Syndrome","status":"COMPLETED","sponsor":"Hope Biosciences Research Foundation","startDate":"2022-02-02","conditions":"Post COVID-19 Syndrome","enrollment":79},{"nctId":"NCT04362189","phase":"PHASE2","title":"Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19","status":"TERMINATED","sponsor":"Hope Biosciences Research Foundation","startDate":"2020-06-30","conditions":"COVID-19","enrollment":48},{"nctId":"NCT02685098","phase":"PHASE1","title":"A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation","status":"COMPLETED","sponsor":"Indiana University","startDate":"2017-01-23","conditions":"Ischemia, Peripheral Arterial Disease, Peripheral Vascular Disease","enrollment":81},{"nctId":"NCT04569409","phase":"PHASE3","title":"Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Wagner Grade 2 Foot Ulcers.","status":"COMPLETED","sponsor":"Anterogen Co., Ltd.","startDate":"2020-07-14","conditions":"Diabetic Foot Ulcer","enrollment":104},{"nctId":"NCT06539429","phase":"PHASE1","title":"Clinical Study to Evaluate Efficacy and Safety of ANT-301 in Patients With Knee Osteoarthritis in Grade III/IV by K/L","status":"ACTIVE_NOT_RECRUITING","sponsor":"Anterogen Co., Ltd.","startDate":"2024-10-22","conditions":"Osteoarthritis, Knee","enrollment":6},{"nctId":"NCT06466850","phase":"NA","title":"Mesenchymal Stem Cells Derived Exosomes in Osteoarthritis Patients","status":"RECRUITING","sponsor":"Isfahan University of Medical Sciences","startDate":"2024-01-01","conditions":"Osteoarthritis, Knee","enrollment":20},{"nctId":"NCT03706482","phase":"PHASE1, PHASE2","title":"Boost Brittle Bones Before Birth","status":"ACTIVE_NOT_RECRUITING","sponsor":"Karolinska Institutet","startDate":"2019-08-12","conditions":"Osteogenesis Imperfecta","enrollment":18},{"nctId":"NCT07106229","phase":"PHASE3","title":"A Study to Investigate the Effectiveness, Safety, and Tolerability of MAG200 Solution for Intra-articular Injection Compared With Placebo in Participants Aged 35 to 75 Years of Age With Symptomatic Osteoarthritis of the Knee.","status":"NOT_YET_RECRUITING","sponsor":"Magellan Stem Cells","startDate":"2025-11","conditions":"Knee Osteoarthristis","enrollment":573},{"nctId":"NCT03211793","phase":"PHASE1, PHASE2","title":"Mesenchymal Stromal Cells as Treatment for Digital Ulcers in Systemic Sclerosis","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2021-10-06","conditions":"Systemic Sclerosis, Digital Ulcer","enrollment":20},{"nctId":"NCT05854641","phase":"PHASE4","title":"Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Peripheral Arterial Disease","status":"RECRUITING","sponsor":"Cell Biopeutics Resources Sdn Bhd","startDate":"2024-01-01","conditions":"Critical Limb Ischemia, Peripheral Arterial Disease","enrollment":10},{"nctId":"NCT05854615","phase":"PHASE4","title":"Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease","status":"RECRUITING","sponsor":"Cell Biopeutics Resources Sdn Bhd","startDate":"2024-01-01","conditions":"Critical Limb Ischemia, Buerger's Disease","enrollment":3},{"nctId":"NCT04776239","phase":"PHASE1, PHASE2","title":"Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease. (ACESO-IHD)","status":"COMPLETED","sponsor":"Joshua M Hare","startDate":"2021-08-16","conditions":"Diabetes Mellitus, Ischemic Heart Disease","enrollment":26},{"nctId":"NCT07146087","phase":"EARLY_PHASE1","title":"Allogeneic Mesenchymal Stem Cell-Derived Exosome Therapy for Progressive Multiple Sclerosis","status":"SUSPENDED","sponsor":"Biocells Medical","startDate":"2020-07-01","conditions":"Multiple Sclerosis","enrollment":20},{"nctId":"NCT05344157","phase":"PHASE1, PHASE2","title":"A First-in-Human Study of XSTEM-OA in Patients With Knee Osteoarthritis","status":"COMPLETED","sponsor":"Xindu Pty Ltd","startDate":"2022-06-22","conditions":"Osteoarthritis, Knee","enrollment":24},{"nctId":"NCT07137559","phase":"","title":"CELZ-201-DDT for the Treatment of Chronic Lower Back Pain","status":"AVAILABLE","sponsor":"Creative Medical Technology Holdings Inc","startDate":"","conditions":"Chronic Back Pain, Degenerative Disc Disease Lumbar","enrollment":""},{"nctId":"NCT07122648","phase":"PHASE2","title":"Phase 2 Trial to Evaluate the Efficacy, Safety of Allogeneic Mitochondria (PN-101) in Patients With Refractory Polymyositis or Dermatomyositis","status":"NOT_YET_RECRUITING","sponsor":"Paean Biotechnology Inc.","startDate":"2025-12","conditions":"Polymyositis, Dermatomyositis","enrollment":36},{"nctId":"NCT04629833","phase":"PHASE3","title":"Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy","status":"RECRUITING","sponsor":"medac GmbH","startDate":"2021-08-16","conditions":"Steroid-refractory Acute Graft-versus-host Disease","enrollment":210},{"nctId":"NCT04392206","phase":"PHASE1","title":"AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses","status":"RECRUITING","sponsor":"Houssam Farres, M.D.","startDate":"2020-05-15","conditions":"End Stage Renal Disease","enrollment":15},{"nctId":"NCT05497401","phase":"PHASE3","title":"A Controlled Study to Evaluate the Efficacy of Allogeneic MesenCure for the Treatment of Patients With ARDS","status":"NOT_YET_RECRUITING","sponsor":"BonusBio Group Ltd","startDate":"2026-04","conditions":"ARDS","enrollment":300},{"nctId":"NCT05532943","phase":"PHASE1, PHASE2","title":"Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis","status":"RECRUITING","sponsor":"Ever Supreme Bio Technology Co., Ltd.","startDate":"2023-09-08","conditions":"Multiple Sclerosis","enrollment":41},{"nctId":"NCT03673748","phase":"PHASE2","title":"Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells","status":"RECRUITING","sponsor":"Red de Terapia Celular","startDate":"2022-12-27","conditions":"Lupus Nephritis, Lupus Erythematosus","enrollment":20},{"nctId":"NCT04255147","phase":"PHASE1","title":"Cellular Therapy for Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ottawa Hospital Research Institute","startDate":"2022-10-17","conditions":"Bronchopulmonary Dysplasia","enrollment":9},{"nctId":"NCT06570291","phase":"PHASE3","title":"Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis","status":"RECRUITING","sponsor":"Wuxi Cellular Biopharmaceutical Group Ltd.","startDate":"2025-02-28","conditions":"Knee Osteoarthritis","enrollment":520},{"nctId":"NCT05984628","phase":"NA","title":"Umbilical Cord Stem Cells for Skin Grafts in Donor Site Wounds","status":"RECRUITING","sponsor":"Fujian Medical University Union Hospital","startDate":"2021-10-20","conditions":"Skin Wound, Scar, Hypertrophic","enrollment":88},{"nctId":"NCT03522545","phase":"PHASE1","title":"Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression","status":"RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2022-04-20","conditions":"Treatment-resistant Bipolar Depression","enrollment":30},{"nctId":"NCT05147675","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for OA","status":"RECRUITING","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2022-12-01","conditions":"Osteoarthritis, Spinal Arthritis","enrollment":92},{"nctId":"NCT04869761","phase":"PHASE1","title":"Stem Cell Therapy for Chronic Kidney Disease","status":"COMPLETED","sponsor":"LaTonya J. Hickson","startDate":"2021-10-07","conditions":"Chronic Kidney Diseases, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1","enrollment":10},{"nctId":"NCT06981338","phase":"PHASE1, PHASE2","title":"Guttmann NeuroRecovery - Viability, Safety, and Efficacy of Intrathecal Wharton's Jelly Mesenchymal Stem Cells and Transcutaneous Spinal Cord Stimulation in Chronic Spinal Cord Injury Rehabilitation","status":"NOT_YET_RECRUITING","sponsor":"Institut Guttmann","startDate":"2025-09-01","conditions":"Spinal Cord Injuries (SCI), Spinal Cord Injury, Traumatic Spinal Cord Injuries","enrollment":10},{"nctId":"NCT03184935","phase":"PHASE1, PHASE2","title":"Research for Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-MDS) in the Treatment of Myelodysplastic Syndrome (MDS)","status":"SUSPENDED","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2025-12-31","conditions":"Myelodysplastic Syndromes","enrollment":40},{"nctId":"NCT03186456","phase":"PHASE1","title":"The Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-ACI) in the Treatment of Acute Cerebral Infarction","status":"SUSPENDED","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2025-12-31","conditions":"Cerebral Infarction","enrollment":40},{"nctId":"NCT03180450","phase":"PHASE1, PHASE2","title":"The Study of Heart Failure With Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-HF)","status":"SUSPENDED","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2025-12-31","conditions":"Heart Failure","enrollment":60},{"nctId":"NCT03180463","phase":"PHASE1, PHASE2","title":"The Study of Early Stage Osteonecrosis of Femoral Head With Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-ONFH)","status":"SUSPENDED","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2025-12-31","conditions":"Osteonecrosis of Femoral Head","enrollment":30},{"nctId":"NCT05039411","phase":"PHASE1","title":"Safety of Allogeneic Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) to Treat Perianal Fistulas w/ Crohn's Disease","status":"RECRUITING","sponsor":"CryoCord Sdn Bhd","startDate":"2022-03-01","conditions":"Perianal Fistula Due to Crohn's Disease, Fistula in Ano","enrollment":5},{"nctId":"NCT05549609","phase":"PHASE1, PHASE2","title":"A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers","status":"RECRUITING","sponsor":"Xintela AB","startDate":"2022-10-26","conditions":"Venous Leg Ulcer","enrollment":6},{"nctId":"NCT06738576","phase":"PHASE1","title":"Allogeneic Use of Expanded Mesenchymal Stem Cells Derived From Adipose Tissue (HC106), Female Urinary Incontinence Women Over 50 Years Old","status":"RECRUITING","sponsor":"Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz","startDate":"2024-12-16","conditions":"Urinary Incontinence Stress","enrollment":60},{"nctId":"NCT06949267","phase":"EARLY_PHASE1","title":"A Study of iMSC for the Prevention of Acute Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation","status":"NOT_YET_RECRUITING","sponsor":"Ruijin Hospital","startDate":"2025-06-01","conditions":"Acute Graft-versus-Host Disease","enrollment":56},{"nctId":"NCT04040348","phase":"PHASE1","title":"Alzheimer's Disease Stem Cells Multiple Infusions","status":"COMPLETED","sponsor":"Bernard (Barry) Baumel","startDate":"2019-10-08","conditions":"Alzheimer Disease","enrollment":6},{"nctId":"NCT04466007","phase":"PHASE2","title":"Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia","status":"COMPLETED","sponsor":"Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz","startDate":"2021-01-11","conditions":"Limb Ischemia, Diabetic Foot","enrollment":90},{"nctId":"NCT04447833","phase":"PHASE1","title":"Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Uppsala University","startDate":"2020-06-17","conditions":"ARDS, Human, COVID","enrollment":7},{"nctId":"NCT06280092","phase":"EARLY_PHASE1","title":"Allogenic Adipose-derived Mesenchymal Stem Cells(AMSCs) for Epilepsy During Deep Brain Stimulation(DBS) Surgery","status":"RECRUITING","sponsor":"Sanjeet S. Grewal","startDate":"2024-12-23","conditions":"Epilepsy","enrollment":5},{"nctId":"NCT05158127","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Skin Ulcer","status":"NOT_YET_RECRUITING","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2025-12","conditions":"Skin Ulcer","enrollment":20},{"nctId":"NCT05018845","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CKD","status":"RECRUITING","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2021-11-06","conditions":"Chronic Kidney Diseases","enrollment":20},{"nctId":"NCT05152394","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Exosomes for Parkinson's Disease","status":"RECRUITING","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2024-08-17","conditions":"Parkinson Disease","enrollment":20},{"nctId":"NCT05147688","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Pulmonary Diseases","status":"RECRUITING","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2021-12-01","conditions":"Pulmonary Disease, Asthma, Chronic Obstructive Pulmonary Disease","enrollment":20},{"nctId":"NCT05018832","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for TBI","status":"NOT_YET_RECRUITING","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2025-12","conditions":"Traumatic Brain Injury","enrollment":20},{"nctId":"NCT05147779","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Peyronie's Disease, ED, and Interstitial Cystitis","status":"RECRUITING","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2021-09-12","conditions":"Erectile Dysfunction, Peyronie's Disease, Interstitial Cystitis","enrollment":20},{"nctId":"NCT05152368","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells Exosomes for Trigeminal Neuralgia","status":"RECRUITING","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2022-09-09","conditions":"Peripheral Neuropathy, Trigeminal Neuralgia","enrollment":20}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Stempeucel - CLI"],"phase":"phase_2","status":"active","brandName":"Allogeneic Mesenchymal Stem Cells","genericName":"Allogeneic Mesenchymal Stem Cells","companyName":"Stempeutics Research Pvt Ltd","companyId":"stempeutics-research-pvt-ltd","modality":"Biologic","firstApprovalDate":"","aiSummary":"Allogeneic Mesenchymal Stem Cells are thought to exert immunomodulatory effects through the release of anti-inflammatory cytokines and growth factors. Used for Treatment of graft-versus-host disease.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}